公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2014 | NR2F1 mutations cause optic atrophy with intellectual disability | Bosch D.G.M.; Boonstra F.N.; Gonzaga-Jauregui C.; Xu M.; De Ligt J.; Jhangiani S.; Wiszniewski W.; Muzny D.M.; Yntema H.G.; Pfundt R.; Vissers L.E.L.M.; Spruijt L.; Blokland E.A.W.; Chen C.-A.; Lewis R.A.; Tsai S.Y.; Gibbs R.A.; MING-JER TSAI ; Lupski J.R.; Zoghbi H.Y.; Cremers F.P.M.; De Vries B.B.A.; Schaaf C.P. | American Journal of Human Genetics | |||
2004 | Recent advances and problems in primary therapy for cervical cancer in Taiwan | Chen C.-A.; CHANG-YAO HSIEH | Journal of the Formosan Medical Association | 19 | 14 | |
2018 | Survival benefit of patients with early-stage ovarian carcinoma treated with paclitaxel chemotherapeutic regimens | Chen C.-A.; CHUN-JU CHIANG ; Chen Y.-Y.; You S.-L.; Hsieh S.-F.; Tang C.-H.; WEN-FANG CHENG | Journal of Gynecologic Oncology | 2 | 2 | |
2010 | Toxic risk of stereotactic body radiotherapy and concurrent helical tomotherapy followed by erlotinib for non-small-cell lung cancer treatment - case report | Hsieh C.-H.; Chang H.-T.; Lin S.-C.; Chen Y.-J.; LI-YING WANG ; Hsieh Y.-P.; Chen C.-A.; Chong N.-S.; Lin S.L.; Chen C.-Y.; Shueng P.-W. | BMC Cancer | 22 | 21 | |
2009 | Whole pelvic helical tomotherapy for locally advanced cervical cancer: Technical implementation of IMRT with helical tomothearapy | Hsieh C.-H.; Wei M.-C.; Lee H.-Y.; Hsiao S.-M.; Chen C.-A.; LI-YING WANG ; Hsieh Y.-P.; Tsai T.-H.; Chen Y.-J.; Shueng P.-W. | Radiation Oncology | 38 | 31 |